Ruohao Xu, Miao Wu, Yawen Wang, Chao Li, Lingji Zeng, Yulian Wang, . . . Jianyu Weng. (2023). Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-β-SMAD2/3 pathway. BMC.
Chicago Style (17th ed.) CitationRuohao Xu, et al. Mesenchymal Stem Cells Reversibly De-differentiate Myofibroblasts to Fibroblast-like Cells by Inhibiting the TGF-β-SMAD2/3 Pathway. BMC, 2023.
MLA (9th ed.) CitationRuohao Xu, et al. Mesenchymal Stem Cells Reversibly De-differentiate Myofibroblasts to Fibroblast-like Cells by Inhibiting the TGF-β-SMAD2/3 Pathway. BMC, 2023.
Warning: These citations may not always be 100% accurate.